BiondVax

BVXV NASDAQ
6.45
+0.44
+7.32%
Closed 16:00 07/18 EDT
Open
6.07
Prev Close
6.01
High
6.45
Low
6.02
Volume
12.57K
Avg Vol (3M)
5.31K
52 Week High
7.26
52 Week Low
3.510
% Turnover
0%
Market Cap
917.30M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers BiondVax BVXV stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing the flu vaccine. BiondVax Pharmaceuticals Ltd develops a biopharmaceutical universal flu vaccine, designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. Its technology utilizes a combination of conserved epitomes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect. The Company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.
MORE >

Recently

Name
Price
%Change